Simon E. Ward
0000-0002-8745-8377
Cardiff University
83 papers found
Refreshing results…
schizophrenia; 1-[4-(4-morpholinylcarbonyl) phenyl]-3-(trifluoromethyl)-4, 5, 6, 7-tetrahydro-1H-indazole; administered alone or with another antipsychotic drug
Pyrazolo [1, 5-A] pyrimidine derivatives
N-inden-2-yl-isopropylsulfonamides as AMPA receptor potentiators
Discovery of N-[(2 S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1 H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator
Mandarin Translationsbph_000
Studies on a series of potent, orally bioavailable, 5-HT 1 receptor ligands—Part II
Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II
Compounds which potentiate AMPA receptor and uses thereof in medicine
Current and Future Perspectives in Psychiatric Drug Discovery.
Thiazoles which potentiate AMPA receptor and medicinal uses thereof
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives
Discovery of Potent, Orally Bioavailable, Selective 5-HT1A/B/D Receptor Antagonists
Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands
Heterocyclic compounds possessing affinity at 5HT1-type receptors and use thereof in therapy
Synthesis of Polyprenylated Acylphloroglucinols Using Bridgehead Lithiation: The Total Synthesis of Racemic Clusianone and a Formal Synthesis of Racemic Garsubellin A.
Heterocyclymethylpiperidines and-piperazines possessing affinity at 5ht-1 type receptors
schizophrenia; 1-[4-(1-pyrrolidinylcarbonyl) phenyl]-3-(trifluoromethyl)-4, 5, 6, 7-tetrahydro-1H-indazole; administered alone or with another antipsychotic drug
glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-${$-2-[4-(6-fluoro-3-pyridinyl) phenyl] cyclopropyl$}$-2-propanesulfonamide
4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors
Missing publications? Search for publications with a matching author name.